These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19702597)

  • 1. Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.
    Bakovic D; Pivac N; Eterovic D; Palada I; Valic Z; Paukovic-Sekulic B; Dujic Z
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):441-6. PubMed ID: 19702597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
    Podbregar M; Voga G
    J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension.
    Bono M; Cases A; Calls J; Gaya J; Jiménez W; Carretero J; Rivera F; Revert L
    Am J Hypertens; 1995 May; 8(5 Pt 1):487-93. PubMed ID: 7662225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
    Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
    Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K; Harada N; Uchiba M; Isobe H
    J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
    Willette RN; Aiyar N; Yue TL; Mitchell MP; Disa J; Storer BL; Naselsky DP; Stadel JM; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):48-53. PubMed ID: 10086986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.